YaoGeJu

← Back to list

Brivaracetam Oral Solution

Matched
Active ingredients (original)
BRIVARACETAM
Dosage form (original)
SOLUTION
Route (original)
ORAL

Read these limits

  1. US patent expiration does not establish Chinese patent expiration. Dates here come from the US Orange Book; Chinese patent status needs separate checking.
  2. The Orange Book lists holder-submitted patents and does not cover all related patents.
  3. “Unmatched” means no English ingredient-name counterpart in the Chinese official-name sources loaded here; it does not mean no Chinese approval or filing. A zero count means a Chinese name is matched but no records were found in the loaded source. Source dates appear below.
  4. This page contains no sales or market-size data and cannot establish development value.
  5. Names on unmatched rows are the original FDA Orange Book names, without Chinese translation. The same ingredient may have a different generic name in China.

US-approved products

Application numbers, product numbers and original fields are retained. Marketing status is shown as listed in the source.

Earliest approval2016/05/12
ANDA applications6
RLD applicantUCB INC

Currently marketed products: 7 · Counts FDA prescription and OTC marketing categories as listed; discontinued or unknown categories are excluded.

Application / product numberBrand name (original)Applicant (original)Dosage form (original)Route (original)Strength (original)Earliest approvalRLD / RSMarketing status (original)Official source
A214922-001BRIVARACETAMMSN LABORATORIES PRIVATE LTDSOLUTIONORALBRIVARACETAM: 10MG/ML2026/02/19N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A218494-001BRIVARACETAMZHEJIANG POLY PHARM CO LTDSOLUTIONORALBRIVARACETAM: 10MG/ML2026/02/23N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A219772-001BRIVARACETAMALKEM LABORATORIES LTDSOLUTIONORALBRIVARACETAM: 10MG/ML2026/02/23N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A220164-001BRIVARACETAMLUPIN INCSOLUTIONORALBRIVARACETAM: 10MG/ML2026/02/23N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A220288-001BRIVARACETAMAUROBINDO PHARMA LTDSOLUTIONORALBRIVARACETAM: 10MG/ML2026/08/10N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
A220385-001BRIVARACETAMREGCON HOLDINGS LLCSOLUTIONORALBRIVARACETAM: 10MG/ML2026/02/23N / NHUMAN PRESCRIPTION DRUGopenFDA ↗
N205838-001BRIVIACTUCB INCSOLUTIONORALBRIVARACETAM: 10MG/ML2016/05/12Y / YHUMAN PRESCRIPTION DRUGopenFDA ↗

Listed US patents

*PED rows, substance/product flags, use codes and delisting-request flags are retained without determining legal effect.

Latest listed patent expiration2026/02/21
Substance patent expiration (DS flag)2026/02/21

This column includes only source rows explicitly flagged DS. A PED row without that flag is not assigned one by this site.

Application / product numberPatent numberListed expirationSubstance / product flagsUse codeDelisting requestOfficial source
N205838-00169114612026/02/21Y / YU-2295—openFDA ↗

Exclusivity source records

FDA exclusivity code list ↗

Latest exclusivity expiration: —

Application / product numberExclusivity codeListed expirationOfficial source
Not listed

Chinese record details

Chinese product landscape ↗

The four-zero filter applies only to matched rows: catalog holders, NHSA approval numbers, applications under review, and companies filing generics this year. Unmatched rows have no Chinese counts. Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.

Catalog holders 0

Company (original)Identifier (original)Source dateOfficial source
No matching records in this loaded source.

NHSA approval numbers 1

Company (original)Identifier (original)Source dateOfficial source
Jiangxi Ke Rui Pharma Co., Ltd. romanized国药准字H20264752300ml:3g—Official source ↗

Under review 2

Company (original)Identifier (original)Source dateOfficial source
Jiangxi Ke Rui Pharma Co., Ltd. romanizedCYHB26014962026/08/04Official source ↗
Shandong Lang Nuo Pharmaceutical Co., Ltd. romanizedCYHS26027472026/11/09Official source ↗

Generic-filing companies this year 2

Company (original)Identifier (original)Source dateOfficial source
Chengdu Ao Bang Pharma Co., Ltd. romanized; Chengdu Li Er Pharma Co., Ltd. romanizedCYHS26002282026/01/20Official source ↗
Shandong Lang Nuo Pharmaceutical Co., Ltd. romanizedCYHS26027472026/11/09Official source ↗

API companies with A status 7

Company (original)Identifier (original)Source dateOfficial source
Zhejiang Dong Ya Pharma Co., Ltd. romanizedY202500000382026/10/10Official source ↗
ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD.Y202400013762026/06/24Official source ↗
Zhejiang Mei Nuo Hua Drug Chemical Co., Ltd. romanizedY202400009592026/06/04Official source ↗
Zhejiang Tian Yu Pharma Co., Ltd. romanizedY202400007762026/06/01Official source ↗
Shanghai Di Sai Nuo Chemical Pharmaceutical Co., Ltd. romanizedY202400007462026/05/07Official source ↗
Shandong Chen Long Pharma Co., Ltd. romanizedY202300005492025/12/29Official source ↗
Jiangxi Ke Rui Pharma Co., Ltd. romanizedY202200012882024/12/27Official source ↗
ZHE JIANG HUA HAI PHARMACEUTICALCO.,LTD.Y202200012752026/03/31Official source ↗

Trial registrations 2025/2026 —

Not loaded

Sources and dates

FDA Orange Book
2026/11/06
CDE acceptance and review
2026/11/16 06:38
Chemical Drug Catalog
2026/11/16 06:35
API registration records
2026/11/16 06:37
NHSA drug code database
2026/10/23
Trial registry
2026/11/16 08:10 · Incomplete coverage

Chinese counts use complete ingredient, dosage-form and route matches. Unmatched and partial rows show name-source matching only and make no finding about Chinese approvals or filings. Trials cover registration-number years 2025/2026 only.

Formulation crosswalk to SOLUTION / ORAL, based on the Chinese Pharmacopoeia general formulation provisions, rule CHP-FORM-028. Chinese Pharmacopoeia general chapter 0123

Comparison generated: 2026/11/16 08:41 · openFDA Orange Book ↗

Name and dosage-form matching sources